Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited (SEHK: 1177) (simplified Chinese: 中国生物制药有限公司; traditional Chinese: 中國生物製藥有限公司; pinyin: zhōng guó shēng wù zhì yào yǒu xiàn gōng sī), shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China.

Sino Biopharmaceutical
listed
Traded as
IndustryPharmaceutical
Founded2000
Headquarters
Hong Kong
,
People's Republic of China
Area served
People's Republic of China
Key people
Chairman: Ms. Theresa Tse
ParentCharoen Pokphand Group
Chinese name
Simplified Chinese中国生物制药有限公司
Traditional Chinese中國生物製藥有限公司
Chinese short name
Simplified Chinese中生制药
Traditional Chinese中生製藥
second alternative short name
Simplified Chinese中国生物制药
Traditional Chinese中國生物製藥
WebsiteSino Biopharmaceutical Limited

Being a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino Biopharm is engaged in researching, developing, producing, and selling biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis through its subsidiaries.[1]

Sino Biopharm is also involved in other minor businesses through its subsidiaries, such as properties, health food, optical glass, optical and auditory products.[2]

References
  1. Sino Biopharmaceutical
  2. About the company


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.